A detailed history of Catalyst Private Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Catalyst Private Wealth, LLC holds 402 shares of LLY stock, worth $314,834. This represents 0.22% of its overall portfolio holdings.

Number of Shares
402
Previous 402 -0.0%
Holding current value
$314,834
Previous $363,000 1.93%
% of portfolio
0.22%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $291,397 - $365,434
402 New
402 $363,000
Q4 2020

Mar 05, 2021

SELL
$130.46 - $172.63 $4,435 - $5,869
-34 Closed
0 $0
Q3 2020

Nov 19, 2020

BUY
$146.22 - $169.13 $4,971 - $5,750
34 New
34 $5,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Catalyst Private Wealth, LLC Portfolio

Follow Catalyst Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Private Wealth, LLC with notifications on news.